Longo N, Li S K, Yan G, Kochambilli R P, Papangkorn K, Berglund D, Ghanem A-H, Ashurst C L, Ernst S L, Pasquali M, Higuchi W I
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
J Inherit Metab Dis. 2007 Nov;30(6):910-5. doi: 10.1007/s10545-007-0675-y. Epub 2007 Oct 5.
Phenylketonuria is an autosomal recessive disorder characterized by elevated concentrations of phenylalanine. Elevated phenylalanine concentrations can impair intellectual functions and the disease is treated with a lifelong diet and frequent monitoring of plasma phenylalanine concentrations. Previous in vitro studies have demonstrated the feasibility of iontophoretically enhanced transdermal transport of phenylalanine. Here we evaluate the feasibility of transdermal iontophoretic extraction of phenylalanine in vivo. Phenylalanine was iontophoretically extracted from the skin of healthy volunteers and of patients with phenylketonuria for up to 6 h and concentrations were compared with those measured in plasma. The amount of phenylalanine iontophoretically extracted from the skin declined over time, suggesting contribution of phenylalanine from the skin in the initial extraction. Phenylalanine iontophoretically extracted from skin correlated with plasma phenylalanine levels at plasma levels above 300 micromol/L. This correlation supports the feasibility of iontophoretic phenylalanine extraction for monitoring phenylketonuria.
苯丙酮尿症是一种常染色体隐性疾病,其特征为苯丙氨酸浓度升高。苯丙氨酸浓度升高会损害智力功能,该疾病需通过终身饮食及频繁监测血浆苯丙氨酸浓度来治疗。先前的体外研究已证明通过离子电渗法增强苯丙氨酸经皮转运的可行性。在此,我们评估体内经皮离子电渗提取苯丙氨酸的可行性。从健康志愿者和苯丙酮尿症患者的皮肤中通过离子电渗法提取苯丙氨酸长达6小时,并将其浓度与血浆中测得的浓度进行比较。随着时间推移,从皮肤中离子电渗提取的苯丙氨酸量下降,这表明在初始提取过程中皮肤中的苯丙氨酸有贡献。当血浆水平高于300微摩尔/升时,从皮肤中离子电渗提取的苯丙氨酸与血浆苯丙氨酸水平相关。这种相关性支持了通过离子电渗提取苯丙氨酸来监测苯丙酮尿症的可行性。